98559-25-2

Basic information

• Product Name: 1-(bromomethyl)-2-methyl-1-cyclohexene
• Synonyms: 1-(bromomethyl)-2-methyl-1-cyclohexene
• CAS NO: 98559-25-2
• Molecular Weight: 189.095
• Mol File: 98559-25-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-(bromomethyl)-2-methyl-1-cyclohexene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(bromomethyl)-2-methyl-1-cyclohexene(98559-25-2)
• EPA Substance Registry System: 1-(bromomethyl)-2-methyl-1-cyclohexene(98559-25-2)

Safety Data

• Hazardous Substances Data: 98559-25-2(Hazardous Substances Data)

Upstream product

• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 
• 122135-83-5 ethyl 2-trifluoromethanesulfonyloxycyclohex-1-enecarboxylate 
• 25662-38-8 2-methyl-1-cyclohexenecarboxylic acid methyl ester 
• 71712-64-6 2-(Diethoxy-phosphoryloxy)-cyclohex-1-enecarboxylic acid methyl ester 
• 41302-34-5 2-(methoxycarbonyl)cyclohexanone 
• 104654-69-5 Ethyl 2-methyl-1-cyclohex-1-ene carboxylate 
• 29474-11-1 (2-methylcyclohex-1-en-1yl)methanol 

Downstream Products

• 129548-21-6 4(R*)-<(2-methyl-1-cyclohexen-1-yl)methyl>-2-isopropyl-4-methyl-3-vinyl-2-cyclopenten-1-one 
• 52329-96-1 1-methyl-2-((phenylcarbonyl)methyl)-1-cyclohexene 
• 133728-62-8 5(R*)-<(2-methyl-1-cyclohexen-1-yl)-methyl>-3-ethoxy-2-isopropyl-5-methyl-2-cyclopenten-1-one 
• 63704-29-0 1,2-bis-(2-methyl-cyclohex-1-enyl)-ethane 

Relevant articles and documents

PhI(OAc)2-mediated alkoxyoxygenation of β,γ-unsaturated ketoximes: Preparation of isoxazolines bearing two contiguous tetrasubstituted carbons

A PhI(OAc)2-promoted dioxygenation of allyl oximes, including one alkoxylation, has been developed. This reaction can give isoxazoline products bearing two contiguous tetrasubstituted carbons. Various oximes substrates bearing different aryl groups and tetrasubstituted-olefin moieties were compatible with the mild reaction conditions. A two-electron oxidation pathway was proposed based on results of preliminary mechanistic studies.

SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS

The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R1, R2, R3, R4, R5, R9 and R10 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.